Core Insights - Prenetics Global Limited, a health-tech and longevity company, has announced that its executive leadership team has made open market purchases of the company's common stock, indicating strong internal confidence in the company's future [1][5]. Executive Purchases - The executive team collectively acquired 111,911 shares for approximately $1,446,887 [2]. - CEO Danny Yeung purchased 40,118 shares for about $502,000 at an average price of $12.51 per share [3]. - CMO Rahul Ramchand bought 60,000 shares for approximately $793,972 at an average price of $13.23 per share [4]. - CFO Stephen Lo acquired 8,000 shares for about $100,915 at an average price of $12.61 per share [4]. - President of Americas David Vanderveen purchased 3,793 shares for approximately $50,000 at an average price of $13.15 per share [5]. Company Overview - Prenetics is a leading health sciences company focused on redefining health and longevity through its flagship brand IM8, co-founded with David Beckham [6]. - IM8 has achieved $100 million in Annual Recurring Revenue within 11 months of launch, marking the fastest growth in the supplement industry [6]. - Prenetics is the first consumer health company to establish a Bitcoin treasury, currently holding 501 BTC, and purchases 1 Bitcoin daily [7]. Product Information - IM8 offers a premium core nutrition product, Daily Ultimate Essentials, which is an all-in-one powder supplement designed to replace 16 different supplements [8].